Skip to content
10-Q

Quarterly Report

PRA Health Sciences, Inc.

0001613859-21-000015

← back to feed
Filed
Apr 29, 2021 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2021 · Apr 26, 2021 64.8M sh
Shares Diluted Q1 2021 · Mar 31, 2021 66.17M sh
Shares Diluted Q1 2021 · Mar 31, 2020 64.34M sh
Capex Q1 2021 · Mar 31, 2021 $18.73M
Capex Q1 2021 · Mar 31, 2020 $21.46M
Operating Cash Flow Q1 2021 · Mar 31, 2021 $192.21M
Operating Cash Flow Q1 2021 · Mar 31, 2020 $60.58M
Long Term Debt Q1 2021 · Mar 31, 2021 $1.15B
Long Term Debt Q1 2021 · Dec 31, 2020 $1.16B
Cash And Equivalents Q1 2021 · Mar 31, 2021 $690.26M
Cash And Equivalents Q1 2021 · Dec 31, 2020 $506.3M
Cash And Equivalents Q1 2021 · Mar 31, 2020 $150.8M
Cash And Equivalents Q1 2021 · Dec 31, 2019 $236.23M
Stockholders Equity Q1 2021 · Mar 31, 2021 $1.56B
Stockholders Equity Q1 2021 · Dec 31, 2020 $1.48B
Stockholders Equity Q1 2021 · Mar 31, 2020 $1.11B
Stockholders Equity Q1 2021 · Dec 31, 2019 $1.09B
Current Liabilities Q1 2021 · Mar 31, 2021 $1.32B
Current Liabilities Q1 2021 · Dec 31, 2020 $1.27B
Total Liabilities Q1 2021 · Mar 31, 2021 $2.73B
Total Liabilities Q1 2021 · Dec 31, 2020 $2.7B
Current Assets Q1 2021 · Mar 31, 2021 $1.6B
Current Assets Q1 2021 · Dec 31, 2020 $1.46B
Total Assets Q1 2021 · Mar 31, 2021 $4.28B
Total Assets Q1 2021 · Dec 31, 2020 $4.18B
Eps Diluted Q1 2021 · Mar 31, 2021 $0.86
Eps Diluted Q1 2021 · Mar 31, 2020 $0.63
Eps Basic Q1 2021 · Mar 31, 2021 $0.89
Eps Basic Q1 2021 · Mar 31, 2020 $0.65
Sga Expense Q1 2021 · Mar 31, 2021 $122.78M
Sga Expense Q1 2021 · Mar 31, 2020 $106.96M
Net Income Q1 2021 · Mar 31, 2021 $56.94M
Net Income Q1 2021 · Mar 31, 2020 $40.66M
Operating Income Q1 2021 · Mar 31, 2021 $69.51M
Operating Income Q1 2021 · Mar 31, 2020 $63.18M
Revenue Q1 2021 · Mar 31, 2021 $933.78M
Revenue Q1 2021 · Mar 31, 2020 $783.71M